Skip to main content

Table 1 Description of samples included in this study by period of collection, gender, age and parasitemia

From: Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature

Region (N)b

Period

Gender (male,  %)

Median age, years (IQRc)

Parasitemia, geometric mean (range)d

Patients infected by P. falciparum a

 Amapá (10)

2004–2005

60

35 (27–46)

1306 (605–2500)

 Rondônia (4)

2008

75

42 (32–52)

5004 (1520–24,650)

Mato Grosso (18)

2002–2012

83

36 (26–43)

1505 (62–56,660)

Patients infected by P. vivax a

 Mato Grosso (13)

2005–2012

92

35 (17–49)

4816 (992–17,500)

 Rondônia (22)

2008

73

41 (23–50)

1840 (95–10,770)

  1. a First line treatment for uncomplicated P. falciparum malaria during sample collection: QN + doxycycline + PQ (2001–2007) and ACT (after 2007). Treatment scheme for P. vivax therapy: CQ + PQ [6]
  2. b State of sample collection and number of isolates analysed
  3. c Interquartile range
  4. d Parasites/µL